Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centers
Objective: To evaluate the efficacy and feasibility of ultrasound-guided percutaneous thermal ablation (TA) for treating benign parotid tumors.Methods: Patients with benign parotid tumors who underwent ultrasound-guided microwave ablation (MWA) or radiofrequency ablation (RFA) between January 2020 a...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | International Journal of Hyperthermia |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/02656736.2023.2290924 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841560903171964928 |
|---|---|
| author | Min Zhuang Yucheng Lin Songsong Wu Man Lu Zirui Jiang Ting Wei Lu Wang Shishi Wang Jie Zou Yi He |
| author_facet | Min Zhuang Yucheng Lin Songsong Wu Man Lu Zirui Jiang Ting Wei Lu Wang Shishi Wang Jie Zou Yi He |
| author_sort | Min Zhuang |
| collection | DOAJ |
| description | Objective: To evaluate the efficacy and feasibility of ultrasound-guided percutaneous thermal ablation (TA) for treating benign parotid tumors.Methods: Patients with benign parotid tumors who underwent ultrasound-guided microwave ablation (MWA) or radiofrequency ablation (RFA) between January 2020 and March 2023 were included in this retrospective study. Change in tumor size (maximum diameter, tumor volume(V), volume reduction rate (VRR)) and cosmetic score (CS) were evaluated during a one-year follow-up period. We also recorded the incidence of any complications associated with TA.Results: A total of 23 patients (13 males and 10 females; median age 65 years, range 5–91 years) were included. The mean VRR at 1, 3, 6, and 12 months after TA was 37.03%±10.23%, 56.52%±8.76%, 82.28%±7.89%, and 89.39%±6.45%, respectively. Mean CS also changed from 3.39 ± 0.66 to 1.75 ± 0.93 (p < 0.001) by the end of follow-up time. Subgroup analysis showed that tumors with smaller initial maximum diameter had a faster CS reduction rate than those with larger initial diameter. The incidence of facial nerve dysfunction was 8.70%.Conclusion: Ultrasound-guided percutaneous TA is an effective and safe treatment option for patients with benign parotid tumors. |
| format | Article |
| id | doaj-art-850bff38f4234cf2899991edbc34dd4c |
| institution | Kabale University |
| issn | 0265-6736 1464-5157 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | International Journal of Hyperthermia |
| spelling | doaj-art-850bff38f4234cf2899991edbc34dd4c2025-01-03T09:30:27ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572024-12-0141110.1080/02656736.2023.2290924Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centersMin Zhuang0Yucheng Lin1Songsong Wu2Man Lu3Zirui Jiang4Ting Wei5Lu Wang6Shishi Wang7Jie Zou8Yi He9Ultrasonography Department, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, ChinaShengli Clinical Medical College of Fujian Medical University, Fuzhou No. 1 Hospital Affiliated with Fujian Medical University, Fuzhou, ChinaDepartment of Ultrasonography, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, ChinaUltrasonography Department, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, ChinaSchool of Health Science of Purdue University, West Lafayette, IN, USAUltrasonography Department, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, ChinaUltrasonography Department, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, ChinaUltrasonography Department, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, ChinaUltrasonography Department, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, ChinaUltrasonography Department, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, ChinaObjective: To evaluate the efficacy and feasibility of ultrasound-guided percutaneous thermal ablation (TA) for treating benign parotid tumors.Methods: Patients with benign parotid tumors who underwent ultrasound-guided microwave ablation (MWA) or radiofrequency ablation (RFA) between January 2020 and March 2023 were included in this retrospective study. Change in tumor size (maximum diameter, tumor volume(V), volume reduction rate (VRR)) and cosmetic score (CS) were evaluated during a one-year follow-up period. We also recorded the incidence of any complications associated with TA.Results: A total of 23 patients (13 males and 10 females; median age 65 years, range 5–91 years) were included. The mean VRR at 1, 3, 6, and 12 months after TA was 37.03%±10.23%, 56.52%±8.76%, 82.28%±7.89%, and 89.39%±6.45%, respectively. Mean CS also changed from 3.39 ± 0.66 to 1.75 ± 0.93 (p < 0.001) by the end of follow-up time. Subgroup analysis showed that tumors with smaller initial maximum diameter had a faster CS reduction rate than those with larger initial diameter. The incidence of facial nerve dysfunction was 8.70%.Conclusion: Ultrasound-guided percutaneous TA is an effective and safe treatment option for patients with benign parotid tumors.https://www.tandfonline.com/doi/10.1080/02656736.2023.2290924Parotid neoplasmsultrasonographyinterventionalablation techniquesmicrowave ablationradiofrequency ablation |
| spellingShingle | Min Zhuang Yucheng Lin Songsong Wu Man Lu Zirui Jiang Ting Wei Lu Wang Shishi Wang Jie Zou Yi He Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centers International Journal of Hyperthermia Parotid neoplasms ultrasonography interventional ablation techniques microwave ablation radiofrequency ablation |
| title | Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centers |
| title_full | Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centers |
| title_fullStr | Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centers |
| title_full_unstemmed | Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centers |
| title_short | Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centers |
| title_sort | ultrasound guided percutaneous thermal ablation of parotid tumors experience from two centers |
| topic | Parotid neoplasms ultrasonography interventional ablation techniques microwave ablation radiofrequency ablation |
| url | https://www.tandfonline.com/doi/10.1080/02656736.2023.2290924 |
| work_keys_str_mv | AT minzhuang ultrasoundguidedpercutaneousthermalablationofparotidtumorsexperiencefromtwocenters AT yuchenglin ultrasoundguidedpercutaneousthermalablationofparotidtumorsexperiencefromtwocenters AT songsongwu ultrasoundguidedpercutaneousthermalablationofparotidtumorsexperiencefromtwocenters AT manlu ultrasoundguidedpercutaneousthermalablationofparotidtumorsexperiencefromtwocenters AT ziruijiang ultrasoundguidedpercutaneousthermalablationofparotidtumorsexperiencefromtwocenters AT tingwei ultrasoundguidedpercutaneousthermalablationofparotidtumorsexperiencefromtwocenters AT luwang ultrasoundguidedpercutaneousthermalablationofparotidtumorsexperiencefromtwocenters AT shishiwang ultrasoundguidedpercutaneousthermalablationofparotidtumorsexperiencefromtwocenters AT jiezou ultrasoundguidedpercutaneousthermalablationofparotidtumorsexperiencefromtwocenters AT yihe ultrasoundguidedpercutaneousthermalablationofparotidtumorsexperiencefromtwocenters |